Literature DB >> 28603138

Single-Molecule Combinatorial Therapeutics for Treating Obesity and Diabetes.

Matthias Tschöp1, Richard DiMarchi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28603138     DOI： 10.2337/dbi16-0068

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  7 in total

1.  MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced obese mice.

Authors:  Shilpak Bele; Shravan Babu Girada; Aramita Ray; Abhishek Gupta; Srinivas Oruganti; Phanithi Prakash Babu; Rahul Sr Rayalla; Shashi Vardhan Kalivendi; Ahamed Ibrahim; Vishwajeet Puri; Venkateswar Adalla; Madhumohan R Katika; Richard DiMarchi; Prasenjit Mitra
Journal:  Elife       Date:  2020-12-22       Impact factor: 8.140

Review 2.  Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists.

Authors:  Kalie L Tommerdahl; Kristen J Nadeau; Petter Bjornstad
Journal:  Adv Chronic Kidney Dis       Date:  2021-07       Impact factor: 4.305

Review 3.  Marine Collagen as A Promising Biomaterial for Biomedical Applications.

Authors:  Ye-Seon Lim; Ye-Jin Ok; Seon-Yeong Hwang; Jong-Young Kwak; Sik Yoon
Journal:  Mar Drugs       Date:  2019-08-10       Impact factor: 5.118

Review 4.  Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production.

Authors:  Kristen E Rohli; Cierra K Boyer; Sandra E Blom; Samuel B Stephens
Journal:  Biomolecules       Date:  2022-02-20

5.  Rapid generation of chemical combinations on a magnetic digital microfluidic array.

Authors:  Yi Zhang; Tza-Huei Wang
Journal:  RSC Adv       Date:  2019-07-12       Impact factor: 4.036

Review 6.  Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes.

Authors:  Megan E Capozzi; Richard D DiMarchi; Matthias H Tschöp; Brian Finan; Jonathan E Campbell
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

7.  A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice.

Authors:  Rachele A Perry; Sarah L Craig; Victor A Gault; Peter R Flatt; Nigel Irwin
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.